Prosecution Insights
Last updated: April 19, 2026

Stealth BioTherapeutics Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18672743 COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, PARKINSON’S DISEASE, PARKINSON’S DISEASE WITH DEMENTIA, DEMENTIA WITH LEWY BODIES, AND MULTIPLE SYSTEM ATROPHY GEMBEH, SHIRLEY V 1615 Non-Final OA May 23, 2024
18620789 METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION NIEBAUER, RONALD T 1658 Final Rejection Mar 28, 2024
18285570 SILICA-BASED FORMULATIONS OF THERAPEUTIC OLIOGPEPTIDES AND PEPTIDOMIMETICS TIEN, LUCY MINYU 1612 Non-Final OA Oct 04, 2023
18460346 METHODS AND COMPOSITIONS FOR TREATING, PREVENTING, INHIBITING, AMELIORATING OR DELAYING THE ONSET OF OPHTHALMIC CONDITIONS NIEBAUER, RONALD T 1658 Non-Final OA Sep 01, 2023
18011354 PRODRUGS OF MITOCHONDRIA-TARGETING OLIGOPEPTIDES KATAKAM, SUDHAKAR 1658 Non-Final OA Dec 19, 2022
18010526 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULAR DYSTROPHY GAMETT, DANIEL C 1647 Final Rejection Dec 15, 2022

Managing Stealth BioTherapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month